Please provide your email address to receive an email when new articles are posted on . Have you had anybody who is actually taking a “generic Restasis”? No? Me either. We’ve certainly gotten all ...

PITTSBURGH, Feb. 3, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received approval from the U.S. Food and Drug Administration ...

The US Food and Drug Administration (FDA) has approved the first generic of cyclosporine ophthalmic emulsion (Restasis) to treat keratoconjunctivitis sicca (dry eye). Restasis has been approved by the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Americans who are boosted are 95 times less likely than unvaccinated people to die of COVID-19, the FDA approved the first generic drug for Restasis to treat dry eye syndrome, and CMS is putting a ...

Allergan, a multibillion-dollar drug corporation, is attempting to perpetrate a fraud on the American people that would make Bernie Madoff blush — even as it casts itself as a victim. Allergan makes ...

Please provide your email address to receive an email when new articles are posted on . They said it would never happen. We would never see it in our lifetimes. It was a dream held by millions, but ...

The Food and Drug Administration has approved Mylan’s generic Restasis (cyclosporine ophthalmic emulsion) 0.05% single-use vials (eye drops) to increase tear production in patients whose tear ...

The US Food and Drug Administration (FDA) on Wednesday denied Allergan's third citizen petition attempting to block the agency from approving generic versions of the company's blockbuster Restasis ...

Allergan said Wednesday it plans to cut more than 1,000 jobs as it braces for one of its bestselling drugs to face generic competition. Chief Executive Brent Saunders said in November that the company ...

Imprimis Pharmaceuticals, Inc. IMMY announced Thursday the release of a 99-cent alternative to Allergan PLC Ordinary Shares AGN's Restasis to address the 30 million Americans suffering from Dry Eye ...